DEUTSCHE BANK AG\ - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$288,995
+0.6%
31,688
+16.7%
0.00%
Q2 2023$287,236
-51.9%
27,149
-44.4%
0.00%
Q1 2023$596,873
+34.0%
48,804
+36.0%
0.00%
Q4 2022$445,271
+22.3%
35,880
+34.5%
0.00%
Q3 2022$364,000
-43.1%
26,667
-23.7%
0.00%
Q2 2022$640,000
+1.3%
34,936
-11.1%
0.00%
Q1 2022$632,000
+6.4%
39,289
-7.4%
0.00%
Q4 2021$594,000
-30.6%
42,445
-7.1%
0.00%
Q3 2021$856,000
-37.8%
45,674
-30.8%
0.00%
-100.0%
Q2 2021$1,376,000
+8.3%
65,964
+46.6%
0.00%0.0%
Q1 2021$1,271,000
-74.3%
44,992
-70.3%
0.00%
-66.7%
Q4 2020$4,944,000
+148.9%
151,367
+133.5%
0.00%
+200.0%
Q3 2020$1,986,000
+94.5%
64,826
+3.5%
0.00%0.0%
Q2 2020$1,021,000
+82.0%
62,651
+11.2%
0.00%0.0%
Q1 2020$561,000
-45.4%
56,340
-24.7%
0.00%0.0%
Q4 2019$1,028,000
-5.3%
74,810
+4.4%
0.00%0.0%
Q3 2019$1,086,000
-28.3%
71,656
-7.0%
0.00%0.0%
Q2 2019$1,515,000
+431.6%
77,057
+345.2%
0.00%
Q1 2019$285,000
+14.9%
17,307
-2.3%
0.00%
Q4 2018$248,000
-92.9%
17,719
-91.1%
0.00%
-100.0%
Q3 2018$3,486,000
+44.5%
199,322
+50.3%
0.00%0.0%
Q2 2018$2,413,000
+29.5%
132,645
+33.4%
0.00%0.0%
Q1 2018$1,863,000
+127.5%
99,458
+85.4%
0.00%0.0%
Q4 2017$819,000
-72.5%
53,645
-73.0%
0.00%
-50.0%
Q3 2017$2,974,000
+530.1%
198,990
+290.8%
0.00%
Q2 2017$472,000
+115.5%
50,913
+104.2%
0.00%
Q1 2017$219,000
+338.0%
24,939
+191.7%
0.00%
Q4 2016$50,0008,551
+8451.0%
0.00%
Q3 2016$0
-100.0%
100
-92.6%
0.00%
Q2 2016$3,0001,3520.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders